William Querbes
33Patents
7h-index
36Co-inventors
65Inventor score
Filing activity: Dec 9, 2011 → Sep 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9322018B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 27 | Active |
| US9771591B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 16 | Active |
| US10570393B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10337010B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10550390B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US10557139B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US9133461B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 10 | Active |
| US11130953B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US9631193B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 5 | Active |
| US10125369B2 | PCSK9 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11034958B2 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10407679B2 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US11306315B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11306314B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11198872B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US10934545B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11525138B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11332743B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11142766B2 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10119143B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 1 | Active |
| US10125364B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 1 | Active |
| US10400239B2 | Compositions and methods for inhibiting expression of the ALAS1 gene | Chemistry; Metallurgy | 1 | Active |
| US11408001B1 | Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US9193973B2 | Compositions and methods for increasing erythropoietin (EPO) production | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.